A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan

被引：0
|
作者：
Yucherng Chen
Taeko Katayose
Soshi Nagaoka
Yongzhe Piao
Kensei Yamaguchi
Hiroya Asou
机构：
[1] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterological Chemotherapy
[2] Saitama Cancer Center,undefined
来源：
Gastric Cancer | 2021年 / 24卷
关键词：
Ramucirumab; Post-marketing surveillance; Gastric cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1320 / 1329
页数：9
相关论文
共 50 条
  • [1] A post-marketing observational study of ramucirumab in patients with gastric cancer in Japan
    Chen, Yucherng
    Katayose, Taeko
    Nagaoka, Soshi
    Piao, Yongzhe
    Yamaguchi, Kensei
    Asou, Hiroya
    [J]. GASTRIC CANCER, 2021, 24 (06) : 1320 - 1329
  • [2] A post-marketing safety study of ramucirumab with FOLFIRI in patients with metastatic colorectal cancer
    Masuishi, Toshiki
    Nagaoka, Soshi
    Jin, Long
    Yoshizawa, Kenichi
    [J]. JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2022, 13 (04) : 1701 - +
  • [3] A post-marketing observational monocentric study
    Moiola, L.
    Pisa, M.
    Sangalli, F.
    Di Cristinzi, M.
    Costa, G. Dalla
    Radaelli, M.
    Esposito, F.
    Boneschi, F. G. Martinelli
    Colombo, B.
    Martinelli, V.
    Comi, G.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2017, 24 : 319 - 319
  • [4] Post-marketing observational study of everolimus in patients with unresectable or metastatic renal cell carcinoma in Japan
    Akaza, Hideyuki
    Kurihara, Ryohei
    Katsura, Aiko
    Harumiya, Miki
    Ushida, Naoko
    [J]. JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2019, 49 (10) : 956 - 964
  • [5] Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Takahashi, Shunji
    Tahara, Makoto
    Ito, Koichi
    Tori, Masayuki
    Kiyota, Naomi
    Yoshida, Katsutoshi
    Sakata, Yukinori
    Yoshida, Akira
    [J]. ADVANCES IN THERAPY, 2020, 37 (09) : 3850 - 3862
  • [6] Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Shunji Takahashi
    Makoto Tahara
    Koichi Ito
    Masayuki Tori
    Naomi Kiyota
    Katsutoshi Yoshida
    Yukinori Sakata
    Akira Yoshida
    [J]. Advances in Therapy, 2020, 37 : 3850 - 3862
  • [7] A post-marketing observational study of the effects of donepezil on patients with Alzheimer disease
    Tinklenberg, JR
    Kraemer, HC
    Yaffe, K
    Ross, L
    Ashford, JW
    Sheikh, J
    Yesavage, JA
    Taylor, JL
    [J]. NEUROPSYCHOPHARMACOLOGY, 2005, 30 : S208 - S208
  • [8] The observational post-marketing study - an observational study of a drug's usage
    Meister, W
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2003, 128 (16) : 859 - 862
  • [9] Safety and effectiveness of ramucirumab and docetaxel: a single-arm, prospective, multicenter, non-interventional, observational, post-marketing safety study of NSCLC in Japan
    Chen, Yucherng
    Nagaoka, Soshi
    Katayose, Taeko
    Sekine, Nobuyuki
    [J]. EXPERT OPINION ON DRUG SAFETY, 2022, 21 (05) : 691 - 698
  • [10] Correction to: Safety and Effectiveness of Lenvatinib in 594 Patients with Unresectable Thyroid Cancer in an All-Case Post-Marketing Observational Study in Japan
    Shunji Takahashi
    Makoto Tahara
    Koichi Ito
    Masayuki Tori
    Naomi Kiyota
    Katsutoshi Yoshida
    Yukinori Sakata
    Akira Yoshida
    [J]. Advances in Therapy, 2021, 38 : 4989 - 4993
12345